Public health laboratories (PHLs) across EU/EEA countries encountered significant challenges during the COVID-19 pandemic, pushing their capabilities to the limit. But here's where it gets controversial—despite these hurdles, the pandemic also served as a catalyst for remarkable advancements in disease surveillance. If you think about it, these labs faced not only an overwhelming surge in testing demand but also grappled with limited resources, staffing shortages, and supply chain disruptions. Their task was further complicated by the urgent need to incorporate cutting-edge digital tools for genomic sequencing and surveillance—tasks that require specialized skills and infrastructure. Imagine the chaos of shortages in vital laboratory equipment just when speed and accuracy mattered most, all while trying to support broader public health efforts.
In reaction to such intense pressure, public health labs responded creatively and proactively. They scaled up their workforce through targeted recruitment and training, rapidly expanded both their physical facilities and their digital capabilities, and sourced supplies via new procurement channels, often with innovative approaches. Cross-sector collaboration became a lifeline—drawing help from military units, animal health laboratories, and private sector partners helped bridge gaps and maintain essential functions during this critical time.
One of the most exciting developments was the leap forward in genomic surveillance, a technological marvel that allowed for rapid sequencing of viral genomes, tracking of variants, and wastewater analysis—techniques that were either new or underutilized before. These methods enabled PHLs to respond swiftly to emerging evidence, adapt procedures on the fly, and implement new protocols that could be shared across borders. Establishing clear guidelines and standardized procedures proved vital, as they helped disseminate best practices and significantly improved the quality and consistency of data collected.
However, not all aspects of the pandemic experience were smooth sailing. Challenges in data sharing, coordination, and collaboration persisted throughout, exposing the need for stronger networks and improved communication channels. Regional and EU-wide collaborations, as well as efforts led by WHO, played a crucial role in enhancing capacity and fostering vital connections. These experiences highlight a critical opportunity: learning from the pandemic to better prepare for future health crises. It’s about finding the right balance—delivering tests that are not only rapid but also accurate and with sufficient volume to inform decision-making at every stage of an outbreak.
Looking ahead, it’s clear that maintaining a solid, operational PHL capacity even during peaceful periods is essential. Countries need to plan for scaling up quickly when emergencies arise—this requires robust coordination mechanisms across various sectors and improved digital infrastructure to facilitate rapid data sharing. To truly fortify our defenses, public health labs require sustained investment in resources, training, and innovative surveillance strategies. Evidence-based approaches, such as ‘right-sizing’ tests like sequencing and PCR analyses, can guide priorities and optimize resource use during crises.
Participants from the laboratories within EU/EEA nations have emphasized the importance of strong support from EU institutions. They advocate for sustained or increased funding to address existing gaps, efforts to compile and share best practices, and targeted research to refine surveillance strategies—making them more efficient and responsive to decision-makers’ needs. Addressing supply chain vulnerabilities through mechanisms like stockpiling and joint procurement is also vital, alongside conducting large-scale preparedness exercises at the EU level. These can serve to improve coordination, communication, and agility when real emergencies strike.
Finally, a clearer understanding of EU actors’ roles and responsibilities in supporting PHLs could streamline responses and improve overall readiness. Reinforcing networks and collaborative efforts among laboratories, other health institutions, and stakeholders will be fundamental in shaping a more resilient public health infrastructure. As we reflect on lessons learned, ask yourself—are we truly doing enough to prepare our laboratories for the next health crisis, or are we only reactive? Your thoughts and opinions are vital in shaping a future where our defenses are stronger and more coordinated.
